Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
- 1 July 2012
- journal article
- review article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 101 (7), 2271-2280
- https://doi.org/10.1002/jps.23146
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenograftsBiomaterials, 2011
- Magnetic nanomaterials for hyperthermia-based therapy and controlled drug deliveryAdvanced Drug Delivery Reviews, 2011
- Annexin A5–Conjugated Polymeric Micelles for Dual SPECT and Optical Detection of ApoptosisJournal of Nuclear Medicine, 2011
- Nanotargeted Radionuclides for Cancer Nuclear Imaging and Internal RadiotherapyJournal of Biomedicine and Biotechnology, 2010
- Molecular imaging and therapy of cancer with radiolabeled nanoparticlesNano Today, 2009
- Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging?Journal of Controlled Release, 2008
- Multifunctional magnetic nanoparticles for targeted imaging and therapyAdvanced Drug Delivery Reviews, 2008
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancerNuclear Medicine and Biology, 2008
- In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapyMolecular Cancer Therapeutics, 2008